Literature DB >> 23249757

SSRIs in a case of selective mutism.

Katharina Manassis1, David Avery.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23249757      PMCID: PMC3529222          DOI: 10.1503/jpn.120194

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  6 in total

1.  Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial.

Authors:  J S Carlson; T R Kratochwill; H F Johnston
Journal:  J Child Adolesc Psychopharmacol       Date:  1999       Impact factor: 2.576

Review 2.  Pharmacotherapy for anxiety disorders in children and adolescents.

Authors:  Ian Kodish; Carol Rockhill; Sheryl Ryan; Chris Varley
Journal:  Pediatr Clin North Am       Date:  2011-02       Impact factor: 3.278

3.  The sounds of silence: language, cognition, and anxiety in selective mutism.

Authors:  Katharina Manassis; Rosemary Tannock; E Jane Garland; Klaus Minde; Alison McINNES; Sandra Clark
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-09       Impact factor: 8.829

4.  Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study.

Authors:  B Black; T W Uhde
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994-09       Impact factor: 8.829

5.  Comparing interventions for selective mutism: a pilot study.

Authors:  Katharina Manassis; Rosemary Tannock
Journal:  Can J Psychiatry       Date:  2008-10       Impact factor: 4.356

Review 6.  Treatment of selective mutism: focus on selective serotonin reuptake inhibitors.

Authors:  Yaman Kaakeh; Janice L Stumpf
Journal:  Pharmacotherapy       Date:  2008-02       Impact factor: 4.705

  6 in total
  1 in total

Review 1.  The use of medication in selective mutism: a systematic review.

Authors:  Katharina Manassis; Beate Oerbeck; Kristin Romvig Overgaard
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-11-09       Impact factor: 4.785

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.